Back to Results
First PageMeta Content
Echinocandins / Mycology / Fungal diseases / Micafungin / Astellas Pharma / Fungemia / Candidiasis / Prescription Drug User Fee Act / Food and Drug Administration / Antifungals / Microbiology / Biology


achanA September 3, 2007 Astellas Announces the Extension of US Regulatory Review for the sNDA of MYCAMINE
Add to Reading List

Document Date: 2008-09-18 21:10:22

Open Document

File Size: 24,36 KB

Share Result on Facebook

City

Tokyo / /

Company

Astellas Pharma US Inc. / Extension of US Regulatory Review / Astellas Pharma Inc. / /

Country

Japan / United States / /

Event

FDA Phase / /

/

MedicalCondition

esophageal candidiasis / candidemia and other Candida infections / fungal infections / Candida infections / /

Organization

U.S. Food and Drug Administration / /

Person

Masafumi Nogimori / /

/

Position

President and CEO / /

Product

MYCAMINE / MYCAMINE ® Japan / /

Technology

transplantation / /

URL

http /

SocialTag